North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Technological advancement in diagnostic procedures for infectious diseases, the increasing prevalence of infectious diseases, a growing elderly population, and the growth of research activities in molecular diagnostic technologies are some major drivers for the global molecular diagnostics in infectious disease testing market.
In 2018, the global Molecular Diagnostics in Infectious Disease Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Molecular Diagnostics in Infectious Disease Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics in Infectious Disease Testing development in United States, Europe and China.
The key players covered in this study
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Next-Generation Sequencing (NGS)
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Molecular Diagnostics in Infectious Disease Testing status, future forecast, growth opportunity, key market and key players.
To present the Molecular Diagnostics in Infectious Disease Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Molecular Diagnostics in Infectious Disease Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.